Heartflow CFO Vikram Verghese sells $1.67m in HTFL shares

Heartflow CFO Vikram Verghese recently sold a substantial amount of his company's shares, amounting to approximately $1.67 million in value. The transactions, which took place in early September 2026, encompassed 33,416 shares. The price range for these sales spanned between $49.6903 and $50.60 per share. These trades were executed under a pre-established Rule 10b5-1 trading plan that Verghese had established on June 4, 2026.

The timing of these sales occurs as Heartflow shares are trading near their 52-week peak of $51.78, having experienced a significant growth of 104% over the past six months. The company's current market capitalization is valued at $4.32 billion. Verghese sold 5,876 shares at $50.60 on September 2, followed by an additional 27,540 shares on September 3 at a weighted average price of $49.6903.

Post these dispositions, he retains ownership of 221,143 shares. According to InvestingPro analysis, Heartflow appears to be overvalued relative to its Fair Value. For those interested in a more in-depth analysis, a comprehensive Pro Research Report on Heartflow is available, featuring expert insights and actionable intelligence.

Recently, HeartFlow Inc. reported its Q2 2026 financial results, which indicated progress despite some challenges. The company reported a smaller-than-expected loss, with adjusted earnings of negative $0.07 per share, beating analyst estimates of a negative $0.19 per share. Revenue for the quarter grew by 48% from the prior year, totaling $64.1 million, fueled by heightened demand for its coronary artery disease diagnostics.

This revenue figure surpassed both Stifel’s projection of $56.7 million and the consensus estimate of $56.6 million. Consequently, Stifel increased its price target for HeartFlow shares to $45.00 from $40.00, maintaining a Buy rating. This growth is primarily attributed to the outperformance of HeartFlow’s plaque and FFRCT businesses.

These developments highlight a robust quarter for HeartFlow. This report was AI-generated and reviewed by an editor. For more information, please refer to the Terms and Conditions.